It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite....
Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in very small quantities. A research team from the Helmholtz Institute for Pharmaceutical...
On 9 and 10 October 2025, the One Lab Retreat of the Helmholtz Centre for Infection Research (HZI) took place at the Wyndham Hannover Atrium. Researchers, managers and task force representatives from all HZI sites came...
Professor Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biology at Saarland University, has been awarded the Mannich Medal by the...
Influenza is much more than just a nasty cold – it is one of the most dangerous infectious diseases worldwide, claiming around half a million lives every year. What makes it particularly insidious is that flu viruses...
Five young scientists were honored in Innsbruck on Wednesday for their internationally outstanding work: The Life Sciences Research Awards Austria 2025 of the Austrian Society for Molecular Biosciences and Biotechnology...
Some of today’s most pressing health challenges include emerging pathogens, rising antibiotic resistance, and chronic infections. To address these issues, a new Helmholtz research building is being constructed in...
A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new way to fine-tune genetic material. Their study, published in Nature Biotechnology, describes an...
Antimicrobial resistance is still an underestimated problem. Resistant bacteria are by no means only found in hospitals, they also occur in the natural environment. Prof. Katharina Schaufler and her team from the...
